154 related articles for article (PubMed ID: 27039262)
1. Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome.
Prasad A; Rabionet R; Espinet B; Zapata L; Puiggros A; Melero C; Puig A; Sarria-Trujillo Y; Ossowski S; Garcia-Muret MP; Estrach T; Servitje O; Lopez-Lerma I; Gallardo F; Pujol RM; Estivill X
J Invest Dermatol; 2016 Jul; 136(7):1490-1499. PubMed ID: 27039262
[TBL] [Abstract][Full Text] [Related]
2. Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome.
Caprini E; Bresin A; Cristofoletti C; Helmer Citterich M; Tocco V; Scala E; Monopoli A; Benucci R; Narducci MG; Russo G
Cell Death Dis; 2018 Dec; 9(12):1178. PubMed ID: 30518749
[TBL] [Abstract][Full Text] [Related]
3. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
[TBL] [Abstract][Full Text] [Related]
4. Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome.
Iżykowska K; Przybylski GK; Gand C; Braun FC; Grabarczyk P; Kuss AW; Olek-Hrab K; Bastidas Torres AN; Vermeer MH; Zoutman WH; Tensen CP; Schmidt CA
Oncotarget; 2017 Jun; 8(24):39627-39639. PubMed ID: 28489605
[TBL] [Abstract][Full Text] [Related]
5. Sézary Syndrome: Translating Genetic Diversity into Personalized Medicine.
Chevret E; Merlio JP
J Invest Dermatol; 2016 Jul; 136(7):1319-1324. PubMed ID: 27342034
[TBL] [Abstract][Full Text] [Related]
6. Novel TBL1XR1, EPHA7 and SLFN12 mutations in a Sezary syndrome patient discovered by whole exome sequencing.
Andersson E; Eldfors S; Edgren H; Ellonen P; Väkevä L; Ranki A; Mustjoki S
Exp Dermatol; 2014 May; 23(5):366-8. PubMed ID: 24689486
[TBL] [Abstract][Full Text] [Related]
7. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue.
Karenko L; Hahtola S; Päivinen S; Karhu R; Syrjä S; Kähkönen M; Nedoszytko B; Kytölä S; Zhou Y; Blazevic V; Pesonen M; Nevala H; Nupponen N; Sihto H; Krebs I; Poustka A; Roszkiewicz J; Saksela K; Peterson P; Visakorpi T; Ranki A
Cancer Res; 2005 Sep; 65(18):8101-10. PubMed ID: 16166283
[TBL] [Abstract][Full Text] [Related]
9. Novel and highly recurrent chromosomal alterations in Sézary syndrome.
Vermeer MH; van Doorn R; Dijkman R; Mao X; Whittaker S; van Voorst Vader PC; Gerritsen MJ; Geerts ML; Gellrich S; Söderberg O; Leuchowius KJ; Landegren U; Out-Luiting JJ; Knijnenburg J; Ijszenga M; Szuhai K; Willemze R; Tensen CP
Cancer Res; 2008 Apr; 68(8):2689-98. PubMed ID: 18413736
[TBL] [Abstract][Full Text] [Related]
10. Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.
Ungewickell A; Bhaduri A; Rios E; Reuter J; Lee CS; Mah A; Zehnder A; Ohgami R; Kulkarni S; Armstrong R; Weng WK; Gratzinger D; Tavallaee M; Rook A; Snyder M; Kim Y; Khavari PA
Nat Genet; 2015 Sep; 47(9):1056-60. PubMed ID: 26258847
[TBL] [Abstract][Full Text] [Related]
11. p53 allele deletion and protein accumulation occurs in the absence of p53 gene mutation in T-prolymphocytic leukaemia and Sezary syndrome.
Brito-Babapulle V; Hamoudi R; Matutes E; Watson S; Kaczmarek P; Maljaie H; Catovsky D
Br J Haematol; 2000 Jul; 110(1):180-7. PubMed ID: 10930996
[TBL] [Abstract][Full Text] [Related]
12. Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes.
Wang L; Ni X; Covington KR; Yang BY; Shiu J; Zhang X; Xi L; Meng Q; Langridge T; Drummond J; Donehower LA; Doddapaneni H; Muzny DM; Gibbs RA; Wheeler DA; Duvic M
Nat Genet; 2015 Dec; 47(12):1426-34. PubMed ID: 26551670
[TBL] [Abstract][Full Text] [Related]
13. Sézary syndrome: old enigmas, new targets.
Nicolay JP; Felcht M; Schledzewski K; Goerdt S; Géraud C
J Dtsch Dermatol Ges; 2016 Mar; 14(3):256-64. PubMed ID: 26972187
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in Sezary syndrome.
Iżykowska K; Przybylski GK
Leuk Lymphoma; 2011 May; 52(5):745-53. PubMed ID: 21323514
[TBL] [Abstract][Full Text] [Related]
16. NOTCH1 signaling as a therapeutic target in Sézary syndrome.
van der Fits L; Qin Y; Out-Luiting JJ; Vermeer KG; Whittaker S; van Es JH; Tensen CP; Vermeer MH
J Invest Dermatol; 2012 Dec; 132(12):2810-7. PubMed ID: 22718117
[TBL] [Abstract][Full Text] [Related]
17. Analysis of p53 and mdm-2 expression in 18 patients with Sézary syndrome.
Marks DI; Vonderheid EC; Kurz BW; Bigler RD; Sinha K; Morgan DA; Sukman A; Nowell PC; Haines DS
Br J Haematol; 1996 Mar; 92(4):890-9. PubMed ID: 8616082
[TBL] [Abstract][Full Text] [Related]
18. Loss of β-arrestin-2 gene and possible functional consequences on Sezary Syndrome.
Cristofoletti C; Bresin A; Caprini E; Russo G; Narducci MG
Cell Cycle; 2019 Jun; 18(11):1292-1294. PubMed ID: 31106661
[TBL] [Abstract][Full Text] [Related]
19. Sézary syndrome with a complex, frameshift p53 gene mutation in a Chernobyl survivor.
Fraser-Andrews EA; McGregor JM; Crook T; Brookes L; Calonje E; Whittaker SJ
Clin Exp Dermatol; 2001 Nov; 26(8):683-5. PubMed ID: 11722457
[TBL] [Abstract][Full Text] [Related]
20. Single-cell RNA-sequencing reveals predictive features of response to pembrolizumab in Sézary syndrome.
Su T; Duran GE; Kwang AC; Ramchurren N; Fling SP; Kim YH; Khodadoust MS
Oncoimmunology; 2022; 11(1):2115197. PubMed ID: 36046812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
